Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
The American Journal of Cardiology
|
March 18, 1999
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty
J C Blankenship, M W Krucoff, S W Werns, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
Journal of the American College of Cardiology
|
June 11, 1999
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study
I K Jang, D F Brown, R P Giugliano, et al.
The American Journal of Cardiology
|
November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators
B M Scirica, D J Moliterno, N R Every, et al.
JAMA
|
April 10, 1996
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry
P H Stone, B Thompson, H V Anderson, et al.
Journal of the American College of Cardiology
|
July 1, 1997
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia
C P Cannon, C H McCabe, P H Stone, et al.
The American Journal of Cardiology
|
February 1, 1997
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators
A M Lincoff, J E Tcheng, R M Califf, et al.
Circulation
|
February 18, 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators
E M Ohman, N S Kleiman, G Gacioch, et al.
Circulation
|
November 1, 1996
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial
S P Schulman, P J Goldschmidt-Clermont, E J Topol, et al.
Journal of the American College of Cardiology
|
December 12, 2001
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
C P Cannon, A Battler, R G Brindis, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
The American Journal of Cardiology
|
March 18, 1999
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty
J C Blankenship, M W Krucoff, S W Werns, et al.
American Heart Journal
|
November 30, 1999
Racial differences in the management of unstable angina: results from the multicenter GUARANTEE registry
B M Scirica, D J Moliterno, N R Every, et al.
Journal of the American College of Cardiology
|
June 11, 1999
A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study
I K Jang, D F Brown, R P Giugliano, et al.
The American Journal of Cardiology
|
November 24, 1999
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators
B M Scirica, D J Moliterno, N R Every, et al.
JAMA
|
April 10, 1996
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry
P H Stone, B Thompson, H V Anderson, et al.
Journal of the American College of Cardiology
|
July 1, 1997
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia
C P Cannon, C H McCabe, P H Stone, et al.
The American Journal of Cardiology
|
February 1, 1997
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators
A M Lincoff, J E Tcheng, R M Califf, et al.
Circulation
|
February 18, 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators
E M Ohman, N S Kleiman, G Gacioch, et al.
Circulation
|
November 1, 1996
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial
S P Schulman, P J Goldschmidt-Clermont, E J Topol, et al.
Journal of the American College of Cardiology
|
December 12, 2001
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
C P Cannon, A Battler, R G Brindis, et al.
Page
of 9